drugset / Trial / NCT06675500

Evaluation of the Role of Magnesium in Prevention of AF Post Cardiac Surgery

NCT06675500

Phase 3 Completed 130 enrolled Ain Shams University
RandomizedParallel-groupDouble-blindPrevention

Summary

Atrial fibrillation (AF) is a common complication after cardiac surgery. Most studies suggest that the frequency ranges between 25-40%. Some studies have shown that serum hypomagnesaemia is common after coronary artery bypass grafts (CABG) and other types of cardiac surgery and is associated with postoperative morbidity such as atrial tachyarrhythmia. The aim of the present study is to investigate the anti-arrhythmic effect of Magnesium Sulfate in prevention of atrial fibrillation post cardiac surgery.

Timeline

Start
2024-11-01
Primary completion
2025-04-15
Completion
2025-04-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Magnesium Sulfate Other / unclassified 1 g Intravenous

Indications